Have a personal or library account? Click to login
Enhancing Glycaemic Control and Diabetes Self-care Behaviours through a Standardised Pharmacist-led Service: Evidence from Community Pharmacies in Southeastern Serbia Cover

Enhancing Glycaemic Control and Diabetes Self-care Behaviours through a Standardised Pharmacist-led Service: Evidence from Community Pharmacies in Southeastern Serbia

Open Access
|Dec 2025

Figures & Tables

Figure 1.

Study flow diagram.
Study flow diagram.

Figure 2.

Monitoring of HbA1c during four-month period in the intervention group (a); in the control group (b).
Monitoring of HbA1c during four-month period in the intervention group (a); in the control group (b).

DSMQ subscale scores at baseline and follow-up_

ScoreBaselineFollow-upP-value
Medication taking6.65±2.237.40±1.80<0.001
Glucose monitoring6.82±2.407.94±1.99<0.001
Eating behaviour6.35±2.197.70±2.13<0.001
Physical activity5.87±2.727.24±2.55<0.001
Cooperation with diabetes team7.59±2.558.54±2.21<0.001

Baseline demographics and patient characteristics_

CharacteristicsIntervention group (n=105)Control group (n=108)P-value
Gender, n(%)
Male47 (44.8%)51 (47.2%)p=0.72
Female58 (55.2%)57 (52.8%)
Diabetes type, n (%)
Type 114 (13.3%)3 (2.8%)p=0.004
Type 291 (86.7%)105 (97.2%)
Age (years), mean±SD (range)60.91±14.7963.30±11.54p=0.19
Education, n (%)
Primary12 (11.5%)11 (10.2%)p=0.47
Secondary69 (65.7%)62 (57.4%)
Bachelor’s degree14 (13.3%)19 (17.6%)
Master’s degree or higher10 (9.5%)16 (14.8%)
Smoking status, n (%)
no84 (80.0%)90 (83.3%)p=0.53
Current smoker21 (20.0%)18 (16.7%)
BMI (kg/m2), mean±SD28.19±5.5429.73±4.36p=0.025
Duration of diabetes (years), n (%)
<1 year6 (5.7%)5 (4.7%)p=0.93
1–5 years17 (16.2%)17 (15.7%)
>5 years82 (78.1%)86 (79.6%)
Family history of diabetes, n (%)
no78 (74.3%)74 (68.5%)p=0.35
yes27 (25.7%)34 (31.5%)
Medication, n (%)
Oral57 (54.3%)76 (70.4%)p=0.001
Insulin only15 (14.3%)1 (0.9%)
Oral +insulin33 (31.4%)37 (28.7%)

Comparison of baseline and follow-up clinical outcomes between intervention and control groups_

OutcomeIntervention group (n=105)Control group (n=108)P-value (intervention vs. control)



BaselineFollow-upP-valueBaselineFollow-upP-valueBaselineFollow-up
HbA1c (%)8.61±1.267.68±0.92<0.0018.84±1.038.70±0.970.3630.230<0.001
FBS (mmol/L)8.52±2.497.77±1.60<0.0018.72±1.748.49±1.640.0950.368<0.05
HDL (mmol/L)1.03±0.231.05±0.410.4781.01±0.381.02±0.630.7950.2310.355
LDL (mmol/L)2.31±0.701.46±0.66<0.0011.79±0.671.81±0.740.700<0.050.110
Tg (mmol/L)1.96±0.791.62±0.760.0681.86±0.881.95±1.980.1480.4600.233
SBP (mmHg)128.9±14.39123.5±13.690.234133.60±19.08134.56±20.440.642<0.05<0.05
DBP (mmHg)83.44±6.1681.29±5.180.22185.49±9.4985.98±10.230.6390.0740.095
DOI: https://doi.org/10.2478/sjph-2025-0026 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English
Page range: 199 - 207
Submitted on: Jul 14, 2025
|
Accepted on: Oct 14, 2025
|
Published on: Dec 1, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Ana Kundalić, Aleksandar Jovanović, Milica Lilić, Ivana Damnjanović, Nikola Stefanović, Aleksandra Catić Đorđević, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.